AMA Urges End to Direct-to-Consumer Advertising for Prescription Drugs

The American Medical Association (AMA) this week called for an end to direct-to-consumer advertising for prescription drugs and implantable medical devices, according to CBS News. The ads contribute to increasing costs, and lead to patient demand for inappropriate treatment, the group says.

“Today’s vote in support of an advertising ban reflects concerns among physicians about the negative impact of commercially driven promotions and the role that marketing costs play in fueling escalating drug prices,” AMA Board Member Dr. Patrice Harris said in a news release. “Direct-to-consumer advertising also inflates demand for new and more expensive drugs, even when these drugs may not be appropriate.”

Drug manufacturers spent $4.5 billion for ads in the last two years, a 30 percent increase, according to the AMA. Prices for prescription drugs rose almost 5 percent this year, the article notes.

Full story of AMA on consumer advertising for prescription drugs at

Published by

Will Savage

Quantum Units Continuing Education provides online CEU training's to licensed professional mental health therapists, counselors, social workers and nurses. Our blog provides updates in the field of news and research related to mental health and substance abuse treatment.